Recent Updates
Recently added Catalysts
CLNN Positive Sentiment Score: 75/100

Clene to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase

Monday, August 5, 2024 1 min read
Key Takeaway: Clene Inc. will present at the Canaccord Genuity 44th Annual Growth Conference on August 13, 2024. The presentation will focus on their efforts in treating neurodegenerative diseases through improving mitochondrial health. Clene's management will also host one-on-one investor meetings to further discuss their clinical initiatives. A webcast of the presentation will be available for online viewing.

Market Sentiment Analysis

POSITIVE FACTORS

  • Clene Inc. is actively engaging with investors.
  • The presentation highlights advancements in treatment for neurodegenerative diseases.
  • Participation in a reputable conference boosts visibility and credibility.

Full Press Release Details

SALT LAKE CITY, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that management will present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase and host 1x1 investor meetings.
Date: August 13, 2024
Time of Presentation: 11:30 am EST
Format: Presentation
1x1 Meetings: Please contact your Canaccord representative.
A webcast of the presentation will be available on the “Events” section of the Clene website. Alternatively, one can register online to view the webcast here: link.

Frequently Asked Questions

What is Clene Inc. focused on?

Clene Inc. specializes in enhancing mitochondrial health and safeguarding neuronal function.

When will Clene present at the Canaccord Genuity conference?

Clene's presentation is scheduled for August 13, 2024, at 11:30 am EST.

What diseases does Clene aim to treat?

Clene targets neurodegenerative diseases, specifically ALS and MS.

How can I view the Clene presentation webcast?

The webcast can be accessed through the 'Events' section on the Clene website.

How can one arrange 1x1 meetings with Clene's management?

1x1 meetings can be organized by contacting your Canaccord representative.

Tags: CLNN Viatris Investor Conferences Healthcare neurodegenerative diseases Canaccord Genuity Clene Inc. healthcare conference
Last updated: Aug 5, 2024